• Eliana Mariño Head of Laboratory of Immunology & Diabetes (Monash University - Australia)

    Plenary session: Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation


  • Dr. Nicole M. Chapman St. Jude Children’s Research Hospital, United States

    Pre-congress course: Fundamentals & perspectives of immunometabolism in health & disease

  • Dr. Will Bailis University of Pennsylvania, United States

    Pre-congress course: Fundamentals & perspectives of immunometabolism in health & disease


  • Ms. Elena Grao-Cruces University of Seville, Spain

    Plenary session: An insight of metabolism and disease from the lipoproteomic perspective

  • Dr. Pascal Mensah Medical Doctor, Spain

    Plenary session: The effect of low-dose IL-22 & IL-2 in the prevention of Type 1 Diabetes

  • Mr. Gunter Schlegel Private medical doctor, Germany

    Plenary session: Cell death and immunometabolism – what we can learn from dying cells

  • Ms. Elena Panzeri St Mary’s University Twickenham, UK

    Plenary session: Tryptophan and kynurenine pathway: roles in inflammation and immune activation

  • Dr. Heidi H. Pak University of Wisconsin-Madison, United States

    Plenary session: Re-evaluating calories and fasting in a dietary restriction paradigm

  • Dr. Kurt Mosetter Center for interdisciplinary therapies, Germany

    Plenary session: Insights into epigenetic principals: how diet and lifestyle factors impact mitochondrial function and energy metabolism

  • Dr. David Moranta University of the Balearic Islands, Spain

    Rapid-fire presentation: Effects of moderate beer intake on the age-associated cognitive and motor impairment: alcoholic fraction interaction and gender differences

  • Prof. Sergio Montserrat de la Paz University of Seville, Spain

    Plenary session: An insight of metabolism and disease from the lipoproteomic perspective


  • Dr. Judith Nicogossian Anthropobiologist – Faculté de médecine de la Méditerranée / CNRS (France)

    Plenary session on Ethics: Data medicine and human medicine – The expected transformation of the patient care pathway

  • Mr. Robert Johnstone Patient Advocate, United Kingdom

    Plenary session on Ethics: Co-production of healthcare: patient as an integral part of the solution

  • Univ.-Prof. Dr. Dr. Christian Schubert Medical University Innsbruck, Austria

    Plenary session on Ethics: Individualized & multi-dimensional approach: the right path to a new paradigm in medicine


  • Ms. Nada Slama Yahia Fares University, Algeria

    Rapid-fire presentation: Preventive effect of NADH in a COPD animal model

  • Dr. Markus Stark Evosan Health Center, Austria

    Workshop: From insulin resistance to fatty liver, inflammation, cardiovascular diseases, and depression – everything is possible

  • Dr. Tiziana Semplici Private medical doctor, Italy

    Plenary session: Lymphocyte subpopulation in oncological diseases:  an assessment tool to verify the immune system and the efficacy of integrated therapies

  • Prof. Martin Raithel Malteser Hospital Erlangen, Germany

    Plenary session: Mast cell activation in health and disease: relationship between gut, microbiota and immune as well as neurovegetative responses

  • Dr. Dan Ning University Hospital Ulm, Germany

    Plenary session: Expression patterns of monocyte subsets in sepsis patients with and without metabolic disorders

  • Dr. Sarah Barbara Myhill Private medical doctor, UK

    Rapid-fire presentation: The dietary and nutritional inputs to optimise the immunological response to micro-immunotherapy

  • Dr. Pilar Muñoz Calero Private medical doctor, Spain

    Workshop: Low dose provocation / neutralization (P/N) immunotherapy in the treatment of a child diagnosed with epilepsy

  • Dr. Roni Moya International University of Bio-Regenerative Sciences, USA

    Plenary session: Mitochondrial peptides and personalized immunotherapies in regenerative biomedicine

  • Dr. Marco Giovanni Monzani Private medical doctor, Italy

    Plenary session: Immunoporosis: role of immune system and micro-immunotherapy in osteoporosis

  • Mrs. Jessica Michieletto CEA Saclay, France

    Plenary session: Metabolomics investigation of the lipopolysaccharide-induced metabolic maturation of dendritic cells

  • Ms. Marta Martínez Velasco Universidad Europea De Madrid, Spain

    Rapid-fire presentation: Phosphoproteome of PBMCs treated with dasatinib revealed deep impairment in essential metabolic pathways involved in higher susceptibility to HIV-1 infection

  • Ms. Chen Li University Hospital Ulm, Germany

    Rapid-fire presentation: Preimplantation factor (PIF) modulates the phagocytic activity of cultured human macrophages of differential phenotypes in response to LPS-induced inflammation

  • Dr. Matthias Kraft BioMed Klinik, Germany

    Plenary session: Metformin – a possible option in cancer chemotherapy

  • Dr. Martin Landenberger Private medical doctor, Germany

    Plenary session: Colitis and Crohn`s disease – an autoimmune inflammation caused by metals?

  • Mag. Anita Frauwallner President of OeProm, Austria

    Workshop: The role of the Microbiome for Pregnancy and Immune System

  • Mrs. Maria Del Mar Ferrà Cañellas University of the Balearic Islands, Spain

    Rapid-fire presentation: BMP4 micro-immunotherapy effects on in vitro gingival fibroblasts and engineered 3D gingival tissue under inflammation

  • Dr. Sabine Fischer Private medical doctor, Germany

    Rapid-fire presentation: PROTEOMIS profile as a diagnostic tool for immunometabolism

  • Dr. Nicola Frisia Private medical doctor, Italy

    Plenary session: Microimmunotherapy and membrane lipidomics: an oncological dinamic duo

  • Dr. Kasey Holland Naturopathic Physician, USA

    Rapid-fire presentation: Targeting Epstein-Barr virus reactivation with antioxidants

  • Prof. María Hernández Bascuñana Nutritionist and dietician, Spain

    Workshop: Vitamin D in the control of auto-immune response: inflammatory bowel disease

  • Dr. Camille Jacques Preclinical Research Department Labo’Life, France

    Plenary session: TNF-α in health and disease. Preclinical evidences of its use in micro-immunotherapy

  • Dr. Elisabeth Johan-Amourette Private dental surgeon, France

    Rapid-fire presentation: Why and how are dentists concerned with Immunometabolism ?

  • Dr. Dolores de la Puerta Private medical doctor, Spain

    Plenary session: Microbiota and intestinal immune homeostasis

  • Dr. Ursula Bubendorfer Private medical doctor, Austria

    Workshop: Immunostressor chronic varicella-zoster virus (VZV): atypical presentations, immunometabolism and immunomodulating therapy options with micro-immunotherapy

  • Ms. Simona Capossela Swiss Paraplegic Research, Switzerland

    Rapid-fire presentation: The effects of probiotics and prebiotics supplementation on elite para-athletes: pilot study on inflammatory and metabolic biomarkers analysis

  • Prof. Karine Benachour Yahia Fares University, Algeria

    Plenary session: NADH: from bed side to bench; its role and function in two experimental models of diabetes and COPD

  • Prof. Mar Blanco Rogel Universitat Oberta de Catalunya, Spain

    Workshop: Mitochondrial dysfunction and NAD+ deficiency as the common nexus between persistent organic dysfunctions

  • Dr. Sibylle Blumenthal Lab4more Munich, Germany

    Plenary session: Analysis of the Gut Microbiome using Next-Generation Sequencing

  • Mr. Jürgen Aschoff Private medical doctor, Germany

    Workshop: Vitamin D receptor inactivation: what are the links with the development of chronic diseases and what are the solutions?

  • Dr. Eytan Barnea BioIncept LLC, United States

    Plenary session: Effective Embryo-Maternal Interaction. Clinical Management to Achieve Immune Homeostasis

  • Ms. Amina Abdellatif Yahia Fares University, Algeria

    Rapid-fire presentation: Preventive effect of NADH on STZ induced diabetes model




Dr. Pascal Mensah
Scientific Director of ICoMI

We are excited to announce that ICoMI2022 will be held as a virtual event

Dear Colleagues,

We are delighted to invite you to the 2nd International Congress of Micro-Immunotherapy (ICoMI) that will take place online on June 2-4, 2022.

ICoMI is an international platform for exchange between health professionals and researchers on Immunomodulation. This 2022 meeting will cover the core fields of Immunology & Metabolism, two challenging areas that are already shaping the roadmap towards precision medicine.

It is today widely known that each stage of the immune response, from antigen presentation to cell differentiation and activation, is intimately linked with cell metabolism.

  • Immune cells are capable of sensing every day changes in our microenvironment, from dietary metabolites to the presence of pathogens or abnormal cells, and trigger or adapt their metabolic signalling programs to their needs.
  • Specific immune responses and inflammation can influence metabolic systemic signalling and contribute to the development of different diseases. A clear example of it may be the link between chronic low-grade inflammation and insulin resistance paving the way to type 2 diabetes.

Every immune response thus depends on and, at the same time, shapes cellular energy management. This crosstalk between immunity and metabolism opens today new perspectives in medicine, and leads to the emerging concept of metabolic reprogramming of immune cells in diseases where chronic inflammation and/or metabolic dysfunctions are key mediators, such as diabetes, autoimmunity or cancer. Therefore, therapeutic approaches like micro-immunotherapy, nutrition and/or microbiome-based therapies may play an important role in the management of these diseases, as part of a global treatment plan.

Looking forward to being connected all together!

Warmest regards,


Dr. Pascal Mensah
Scientific Director of ICoMI


Key topics

Immunometabolism as an approach and immunomodulation as a strategy encompass a wide range of topics. The following topics will be addressed at ICoMI2022:

1. Metabolic control of immune function

  • Impact of the microenvironment (nutrients, metabolites, cytokines) on immune cells
  • Metabolic pathways (glycolysis, OXPHOS, etc.) in different immune cell subtypes (effector T cells, NK cells, regulatory T cells, etc.)
  • Nutrient sensors as key cell regulators (mTOR, AMPK, etc.)
  • Mitochondria & bioenergetics
  • Genetics & epigenetics
  • Etc.

2. Dysmetabolism, chronic inflammation & associated diseases

  • Infectious disorders (EBV, SARS-CoV-2, HIV, etc.)
  • Obesity, diabetes
  • Cardiovascular diseases
  • Autoimmunity
  • Cancer
  • Etc.

3. Therapeutic interventions & immunometabolic reprogramming

  • Low dose immunotherapy (micro-immunotherapy)
  • Other pharmacological interventions & immunomodulatory strategies
  • Microbiota-based therapies & metabolites as immune regulators
  • Nutritional immunology
  • Immunometabolic effects of diet & exercise
  • Etc.

4. Diagnostic tools & biomarkers

  • Biomarkers of inflammation
  • Lymphocyte typing
  • Metabolic & oxidative stress biomarkers
  • Microbiome analysis
  • Microbial detection methods
  • Nutrient monitoring
  • Genetic & epigenetic profiling
  • Etc.


Meet the Committees of the 2nd International Congress of Micro-immunotherapy The Clinical and Scientific Committees of ICoMI2022 will be in charge of overseeing the scientific quality and consistency of the conferences being held during ICoMI and will help build the Congress programme. ICoMI2022 Committees consist of 9 individuals: 4 members are part of the Clinical Committee, 4 members are part of the Scientific Committee, together with the Scientific and Medical Director as chair. Discover their path and areas of expertise!

Scientific and Medical Director

Scientific Committee

Clinical Committee


What does Immunometabolism mean?

The interplay between immunological and metabolic processes

On the cell level:

  • The immune cell metabolism is not only influenced by the microenvironment (antigenic stimuli, cytokines, nutrients and metabolites, etc.), but also by the activation and differentiation status of the cell itself.
  • Conversely, metabolism is a key determinant of immune cell function.

On the systemic level:

  • The immune status and inflammation can have an impact on metabolic system and viceversa.

Thus, health depends on immune and metabolic balance, whereas immunometabolic dysregulation has been associated with different diseases like diabetes, cancer or cardiovascular diseases, among others.

Micro-immunotherapy, at the cutting-edge of immunity & metabolism

The emerging field of immunometabolism opens new perspectives in the prevention and treatment of chronic diseases.

It is becoming increasingly clear that, by combining immunologic and metabolic approaches, a more efficient and precise management of these diseases may be achieved.

Micro-immunotherapy, i.e. low-dose immunotherapy, is a treatment that uses cytokines to regulate immune function and cellular metabolism towards homeostasis, and can play an important role within a global treatment plan.

For more information: “Fundamentals of immunometabolism and implications for health and disease”